We are live on
!
Find out more
Atossa Therapeutics
ATOS
ATOS
77 hedge funds and large institutions have $31.2M invested in Atossa Therapeutics in 2024 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 20 increasing their positions, 14 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
643% more call options, than puts
Call options by funds: $765K | Put options by funds: $103K
65% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 17
43% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 14
15% more funds holding
Funds holding: 67 → 77 (+10)
0.36% more ownership
Funds ownership: 1.03% → 1.39% (+0.36%)
10% less capital invested
Capital invested by funds: $34.7M → $31.2M (-$3.55M)
Holders
77
Holders Change
+10
Holders Change %
+14.93%
% of All Funds
1.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
20
Reduced
14
Closed
17
Calls
$765K
Puts
$103K
Net Calls
+$662K
Net Calls Change
+$377K
Top Buyers
| 1 |
BlackRock
New York
|
+$9.51M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.3M |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.72M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.08M |
| 5 |
Bank of New York Mellon
New York
|
+$589K |
Top Sellers
| 1 |
LCM
Laurion Capital Management
New York
|
-$4.01M |
| 2 |
Millennium Management
New York
|
-$1.48M |
| 3 |
Goldman Sachs
New York
|
-$776K |
| 4 |
HF
HRT Financial
New York
|
-$524K |
| 5 |
Morgan Stanley
New York
|
-$456K |
